Table 4.

Summarizes the most relevant findings of the HLA genotyping MS patients as a function of Odds Ratio (OR) and compare the numbers to the roles given by the researchers in other ethnic groups.

Summary of findings of Preliminary Study
Allele	OR* (95%Cl)	p <0.1	Comments
HLA-A *30	7.2	0.089	Most frequent in MS patient - marginally significant Amirzargar et al. (2005) Optical Neuritis; Bitti et al. (2001)
HLA-A *02	0.7	0.552	Smestad et al. (2007), Decreased risk of MS Bergamaschi et al. (2010); Protective allele
HLA-DRB1 *01	11.0	0.041	DeLuca et al. (2007) MS benign disease
HLA-DRB1 *03	4.3	0.054	Barcellos et al. (2006); Brynedal et al. (2007); Dean et al. (2007) Risk of MS
HLA-DQB1 *04	0.23	0.066	Marginally significant; Protective role; not described before